Risk factors associated with hepatitis B and C in rural population of Burera district, Rwanda

Pan Afr Med J. 2020 Feb 12:35:43. doi: 10.11604/pamj.2020.35.43.16226. eCollection 2020.

Abstract

Introduction: Several studies have shown that older people have a higher risk of exposure to viral hepatitis B and C than younger people. This study aimed to determine the seroprevalence of hepatitis B and C and their associated factors in people aged 45+ years old in Burera, a rural district of Rwanda.

Methods: A cross sectional study was conducted from July to December 2017 during a mass campaign of hepatitis B (HBV) and hepatitis C (HCV) screening and vaccination of eligible populations against HBV in Burera District. Blood samples were collected and hepatitis B surface antigen (HBsAg) and an antibody against hepatitis C (Anti-HCV) were detected using an Enzyme-Linked Immuno-Sorbent Assay (ELISA). The associated factors were identified using a structured questionnaire and the data was analyzed using SPSS software.

Results: Of the 374 people included in this study, 53.2% were females. The median age was 56 years old with an interquartile range (IQR) of 50 - 63 years old. The prevalence of HBV and HCV infection was 6.4% and 9.4%, respectively, with 0.3% co-infection rate. Age, social economic level, history of blood transfusion, history of never using a condom, as well as a history of injury with a used sharp material were significantly associated with HCV infection.

Conclusion: The study showed a high seroprevalence of both HBV and HCV in Burera's elderly population aged 45+ years. Several factors associated with HBV and HCV in this study could be prevented through education and improved hygiene.

Keywords: Hepatitis B virus; Rwanda; hepatitis C virus.

MeSH terms

  • Coinfection / epidemiology
  • Cross-Sectional Studies
  • Female
  • Hepatitis B / blood
  • Hepatitis B / diagnosis
  • Hepatitis B / epidemiology*
  • Hepatitis B Surface Antigens / blood
  • Hepatitis C / blood
  • Hepatitis C / diagnosis
  • Hepatitis C / epidemiology*
  • Hepatitis C Antibodies / blood
  • Humans
  • Male
  • Mass Screening / methods
  • Mass Screening / statistics & numerical data
  • Middle Aged
  • Prevalence
  • Risk Factors
  • Rural Population / statistics & numerical data
  • Rwanda / epidemiology
  • Seroepidemiologic Studies

Substances

  • Hepatitis B Surface Antigens
  • Hepatitis C Antibodies